Phaseline

Companies › Pharmanutra

Pharmanutra: clinical trials, targets and expected readouts

1 active drug program in 1 registered trial: 1 Phase 4; Hematology.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
Sucrosomial® Iron (Sideral® Forte)
Dietary iron supplement with sucrosomial delivery technology
IRONPhase 4Anemia–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT07308769Sucrosomial® Iron (Sideral® Forte)Phase 4AnemiaHematologyOct 2026

Targets

IRON (1)

Companies with the same targets

–

Companies built like this

Vega Therapeutics VarmX MIBIO PTE. Bioverativ, a Sanofi company Hangzhou Gensciences Biopharmaceutical

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.